A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX

Clinical trial NCT00319592 · COMPLETED

Trial details

NCT number: NCT00319592
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Japanese Encephalitis

Start date: 2005-05-01
Primary completion: 2006-09-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.